Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Cell cycle disruption and apoptotic activity of 3-aminothiazolo[3,2-a]benzimidazole-2-carbonitrile and its homologues.

Sarhan AA, Al-Dhfyan A, Al-Mozaini MA, Adra CN, Aboul-Fadl T.

Eur J Med Chem. 2010 Jun;45(6):2689-94. doi: 10.1016/j.ejmech.2010.02.025. Epub 2010 Feb 16.

PMID:
20226574
2.

Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.

Ranganatha SR, Kavitha CV, Vinaya K, Prasanna DS, Chandrappa S, Raghavan SC, Rangappa KS.

Arch Pharm Res. 2009 Oct;32(10):1335-43. doi: 10.1007/s12272-009-2000-9. Epub 2009 Nov 8.

PMID:
19898794
3.

Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.

Stýskala J, Stýskalová L, Slouka J, Hajdúch M.

Eur J Med Chem. 2008 Mar;43(3):449-55. doi: 10.1016/j.ejmech.2007.01.008. Epub 2007 Jan 25.

PMID:
18272255
4.

Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, part 3.

Hranjec M, Kralj M, Piantanida I, Sedić M, Suman L, Pavelić K, Karminski-Zamola G.

J Med Chem. 2007 Nov 15;50(23):5696-711. Epub 2007 Oct 13.

PMID:
17935309
5.

Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.

Romero-Castro A, León-Rivera I, Avila-Rojas LC, Navarrete-Vázquez G, Nieto-Rodríguez A.

Arch Pharm Res. 2011 Feb;34(2):181-9. doi: 10.1007/s12272-011-0201-5. Epub 2011 Mar 6.

PMID:
21380799
6.

Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.

Galal SA, Hegab KH, Hashem AM, Youssef NS.

Eur J Med Chem. 2010 Dec;45(12):5685-91. doi: 10.1016/j.ejmech.2010.09.023. Epub 2010 Sep 17.

PMID:
20884089
7.

Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.

Sondhi SM, Rani R, Singh J, Roy P, Agrawal SK, Saxena AK.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2306-10. doi: 10.1016/j.bmcl.2010.01.147. Epub 2010 Feb 2.

PMID:
20188544
8.

Synthesis and anticancer activity of novel benzimidazole and benzothiazole derivatives against HepG2 liver cancer cells.

Youssef AM, Malki A, Badr MH, Elbayaa RY, Sultan AS.

Med Chem. 2012 Mar;8(2):151-62.

PMID:
22385181
9.

Microwave supported synthesis of some novel 1,3-diarylpyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities.

Demirayak S, Kayagil I, Yurttas L.

Eur J Med Chem. 2011 Jan;46(1):411-6. doi: 10.1016/j.ejmech.2010.11.007. Epub 2010 Nov 12.

PMID:
21122952
10.
11.

Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives.

Garuti L, Roberti M, Malagoli M, Rossi T, Castelli M.

Bioorg Med Chem Lett. 2000 Oct 2;10(19):2193-5.

PMID:
11012027
12.

Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.

Hranjec M, Starčević K, Pavelić SK, Lučin P, Pavelić K, Karminski Zamola G.

Eur J Med Chem. 2011 Jun;46(6):2274-9. doi: 10.1016/j.ejmech.2011.03.008. Epub 2011 Mar 10.

PMID:
21439689
13.

Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.

Starcević K, Kralj M, Ester K, Sabol I, Grce M, Pavelić K, Karminski-Zamola G.

Bioorg Med Chem. 2007 Jul 1;15(13):4419-26. Epub 2007 Apr 25.

PMID:
17482821
14.

Syntheses and cell-based phenotypic screen of novel 7-amino pyrido[2,3-d]pyrimidine-6-carbonitrile derivatives as potential antiproliferative agents.

Yang T, He H, Ang W, Yang YH, Yang JZ, Lin YN, Yang HC, Pi WY, Li ZC, Zhao YL, Luo YF, Wei Y.

Molecules. 2012 Feb 24;17(3):2351-66. doi: 10.3390/molecules17032351.

15.

Novel benzimidazole derivatives as expected anticancer agents.

Nofal ZM, Soliman EA, Abd El-Karim SS, El Zahar MI, Srour AM, Sethumadhavan S, Maher TJ.

Acta Pol Pharm. 2011 Jul-Aug;68(4):519-34.

17.

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis.

Pojarová M, Kaufmann D, Gastpar R, Nishino T, Reszka P, Bednarski PJ, von Angerer E.

Bioorg Med Chem. 2007 Dec 1;15(23):7368-79. Epub 2007 Aug 21.

PMID:
17889547
18.

Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.

Thimmegowda NR, Nanjunda Swamy S, Kumar CS, Kumar YC, Chandrappa S, Yip GW, Rangappa KS.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):432-5. Epub 2007 Oct 24.

PMID:
17981032
19.

Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.

Refaat HM.

Eur J Med Chem. 2010 Jul;45(7):2949-56. doi: 10.1016/j.ejmech.2010.03.022. Epub 2010 Mar 25.

PMID:
20399544
20.

(2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide induces apoptosis and cell cycle arrest in HL-60 cells.

Chen CJ, Hsu MH, Kuo SC, Lai YY, Chung JG, Huang LJ.

Anticancer Res. 2007 Jan-Feb;27(1A):343-9.

Supplemental Content

Support Center